Eckhart Weidmann

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

Mathias Rummel, N. Niederle, Georg Maschmeyer et al. · The Lancet · 2013 · 1.5K citations

Lymphoid Neoplasia, Rituximab Versus Chop, Oncology +10

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Steven M. Horwitz, Owen A. O’Connor, Barbara Pro et al. · The Lancet · 2018 · 707 citations · Full text

High Levels of Wilms' Tumor Gene (wt1) mRNA in Acute Myeloid Leukemias Are Associated With a Worse Long-Term Outcome

Lothar Bergmann, Cornelius Miething, Ulrich Maurer et al. · Blood · 1997 · 352 citations · Full text

Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology

Bernard Conrad, Eckhart Weidmann, Giuliana Trucco et al. · Nature · 1994 · 311 citations

Metabolic Syndrome, Superantigen Involvement, Diabetes +7

Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure

Veronica Miller, Caroline Sabin, Kurt Hertogs et al. · AIDS · 2000 · 224 citations